•  
  •  
  •  
  •  

2025-10-01 08:24:42

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Reliance Infrastructure Ltd clarifies on media reports related to ED survey under FEMA
  • Sri Lotus Developers & Realty Ltd launches two new projects
  • Tamilnad Mercantile Bank join Hands with Wegofin for Payment Aggregator Business
  • Waaree Energies Ltd commences Commercial Production of 950 MW Solar Module Line Manufacturing facility
  • Bizotic Commercial Ltd receives orders worth Rs. 72.25 crores

Keywords Selected:  MorepenLaboratories

Stock Report

  • Morepen Laboratories Ltd consolidated Q1 FY26 PAT lower at Rs. 11.40 crore
  • Morepen Laboratories Limited approves final dividend of Rs. 0.20
  • Morepen Laboratories Ltd consolidated Q4 FY2024-25 net profit lower at Rs. 20.31 crores
  • Morepen to Launch Resmetirom - a New Drug for Fatty Liver
  • Morepen Double Down on Rx Innovation
  • Morepen Set For Bold Expansion: To Add 1000 Medical Representatives
  • Morepen secures Loratadine approval for export to China
  • Morepen Laboratories Limited approves term loan facility from Shinhan Bank
  • Empamore by Morepen: Revolutionizing Diabetes Care with Affordable, High-Quality Treatment
  • Morepen Laboratories Limited approves hiving off of Medical Devices Business
  • Morepen Laboratories Ltd consolidated Q3 FY24 net profit higher at Rs. 31.99 crores
  • Morepen Laboratories Ltd consolidated Q2 FY2023-24 net profit increases to Rs. 21.25 crores
  • Morepen Laboratories' Q1FY24 consolidated net profit climbs to Rs. 14.63 crores
  • Morepen Laboratories Ltd consolidated Q4FY23 profit at Rs. 8.24 crores
  • Morepen Laboratories Ltd announces successful completion of USFDA inspection of API facility at Baddi
  • Morepen Laboratories Ltd posts consolidated PAT of Rs. 8.99 crores in Q3FY23
  • Morepen Laboratories Ltd reports consolidated PAT of Rs. 15.81 crores in Q2FY23
  • Morepen Laboratories consolidated Q1FY23 PAT falls to Rs. 5.62 crores
  • Morepen Laboratories Ltd Q4FY22 consolidated net profit slides to Rs. 12.32 crores
  • Morepen Laboratories Q3FY22 consolidated PAT falls to Rs. 21.52 crores
  • Morepen Laboratories Ltd consolidated Q2FY22 PAT at Rs. 37.36 crore

Latest Post

  • Reliance Infrastructure Ltd clarifies on media reports related to ED survey under FEMA
  • Sri Lotus Developers & Realty Ltd launches two new projects
  • Tamilnad Mercantile Bank join Hands with Wegofin for Payment Aggregator Business
  • Waaree Energies Ltd commences Commercial Production of 950 MW Solar Module Line Manufacturing facility
  • Bizotic Commercial Ltd receives orders worth Rs. 72.25 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024